These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 22201765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of new mutations in primary hyperoxaluria type 1 (PH1).
    von Schnakenburg C, Rumsby G.
    J Nephrol; 1998; 11 Suppl 1():15-7. PubMed ID: 9604803
    [Abstract] [Full Text] [Related]

  • 8. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
    Danpure CJ.
    Am J Nephrol; 2005; 25(3):303-10. PubMed ID: 15961951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.
    Dindo M, Oppici E, Dell'Orco D, Montone R, Cellini B.
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [Abstract] [Full Text] [Related]

  • 13. Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants.
    Cellini B, Montioli R, Voltattorni CB.
    Biochim Biophys Acta; 2011 Nov; 1814(11):1577-84. PubMed ID: 21176891
    [Abstract] [Full Text] [Related]

  • 14. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
    Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, Lumb MJ, Guttridge KM, Jennings PR, Scheinman JI, Mauer SM.
    Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
    [Abstract] [Full Text] [Related]

  • 15. Partial deletion of the AGXT gene (EX1_EX7del): A new genotype in hyperoxaluria type 1.
    Nogueira PK, Vuong TS, Bouton O, Maillard A, Marchand M, Rolland MO, Cochat P, Bozon D.
    Hum Mutat; 2000 Apr; 15(4):384-5. PubMed ID: 10737993
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene.
    von Schnakenburg C, Rumsby G.
    J Med Genet; 1997 Jun; 34(6):489-92. PubMed ID: 9192270
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB, Lian Q, Wong SG.
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.